Investment accounts
Adult accounts
Child accounts
Choosing Fidelity
Choosing Fidelity
Why invest with us Current offers Fees and charges Open an account Transfer investments
Financial advice & support
Fidelity’s Services
Fidelity’s Services
Financial advice Retirement Wealth Management Investor Centre (London) Bereavement
Guidance and tools
Guidance and tools
Choosing investments Choosing accounts ISA calculator Retirement calculators
Shares
Share dealing
Choose your shares
Tools and information
Tools and information
Share prices and markets Chart and compare shares Stock market news Shareholder perks
Pensions & retirement
Pensions, tax & tools
Saving for retirement
Approaching / In retirement
Approaching / In retirement
Speak to a specialist Creating a retirement plan Taking tax-free cash Pension drawdown Annuities Investing in retirement Investment Pathways
Director dealings: Wife of Shaftesbury CEO makes share purchase
(Sharecast News) - Shaftesbury Capital revealed on Thursday that Jane Hawksworth, the wife of chief executive Ian Hawksworth, had acquired 88,888 ordinary shares in the FTSE 250-listed property investment and development company. Hawksworth purchased the shares at an average price of 124.00p each, for a total value of £110,221.12.
Following the purchase, Ian Hawksworth and his closely associated persons hold a beneficial interest in 2.24m ordinary Shaftesbury shares, which represents 0.11% of the company's issued share capital.
As of 1550 GMT, Shaftesbury shares were up 1.40% at 123.40p.
Reporting by Iain Gilbert at Sharecast.com
Top Director Buys
Ninety One (N91) Director name: Toit,Hendrik du Amount purchased: 172,957 @ 163.11p Value: £282,110.17
Ninety One (N91) Director name: McFarland,Kim Mary Amount purchased: 153,887 @ 167.47p Value: £257,714.56
Bae Systems (BA.) Director name: Kirk,Ewan Amount purchased: 10,000 @ 1,256.00p Value: £125,600.00
Shaftesbury Capital (SHC) Director name: Hawksworth,Ian Amount purchased: 88,888 @ 124.00p Value: £110,221.12
Ninety One (N91) Director name: McFarland,Kim Mary Amount purchased: 51,556 @ 165.00p Value: £85,067.40
Asos (ASC) Director name: Barker,William Amount purchased: 17,500 @ 364.57p Value: £63,800.10
Ninety One (N91) Director name: Toit,Hendrik du Amount purchased: 32,269 @ 167.86p Value: £54,168.16
Bae Systems (BA.) Director name: Piasecki,Nicole Amount purchased: 3,132 @ 1,595.13p Value: £49,959.32
Abrdn Diversified Income And Growth (ADIG) Director name: Walter,Davina Amount purchased: 52,000 @ 77.63p Value: £40,369.29
Volex (VLX) Director name: Boaden,Jon Amount purchased: 13,190 @ 293.00p Value: £38,646.70
Bhp Group Limited Npv (di) (BHP) Director name: Hinchliffe ,Michelle Amount purchased: 1,599 @ $43.77 Value: $37,044.55
Volex (VLX) Director name: Boaden,Jon Amount purchased: 9,981 @ 293.00p Value: £29,244.33
Bt Group (BT.A) Director name: Key,Matthew Amount purchased: 28,000 @ 104.00p Value: £29,120.00
Primary Health Properties (PHP) Director name: Rawal,Bandhana Amount purchased: 27,549 @ 90.30p Value: £24,876.75
Redcentric (RCN) Director name: Scott,Oliver Rupert Andrew Amount purchased: 5,000 @ 132.20p Value: £6,610.00
Redcentric (RCN) Director name: Scott,Oliver Rupert Andrew Amount purchased: 5,000 @ 131.50p Value: £6,575.00
Redcentric (RCN) Director name: Scott,Oliver Rupert Andrew Amount purchased: 4,000 @ 131.25p Value: £5,250.00
Gooch & Housego (GHH) Director name: Bullard,Gary Amount purchased: 377 @ 494.00p Value: £1,862.38
Gooch & Housego (GHH) Director name: Bullard,Gary Amount purchased: 263 @ 494.00p Value: £1,299.22
Ninety One (N91) Director name: Toit,Hendrik du Amount purchased: 118 @ 164.00p Value: £193.52
Direct Line Insurance Group (DLG) Director name: Manser,Neil Amount purchased: 93 @ 162.43p Value: £151.06
Direct Line Insurance Group (DLG) Director name: Greenwood,Jon Amount purchased: 92 @ 162.43p Value: £149.44
Top Director Sells
Volex (VLX) Director name: Boaden,Jon Amount sold: 20,171 @ 293.00p Value: £59,101.03
Abrdn Diversified Income And Growth (ADIG) Director name: Walter,Davina Amount sold: 31,785 @ 77.40p Value: £24,601.59
Maxcyte (di) (MXCT) Director name: Johnston ,John Amount sold: 896 @ $4.59 Value: $3,391.31
Maxcyte (di) (MXCT) Director name: Johnston ,John Amount sold: 901 @ $4.51 Value: $3,350.80
Maxcyte (di) (MXCT) Director name: Johnston ,John Amount sold: 737 @ $4.63 Value: $2,810.77
Maxcyte (di) (MXCT) Director name: Johnston ,John Amount sold: 620 @ $4.61 Value: $2,356.89
Maxcyte (di) (MXCT) Director name: Johnston ,John Amount sold: 467 @ $4.59 Value: $1,769.49
Maxcyte (di) (MXCT) Director name: Johnston ,John Amount sold: 432 @ $4.57 Value: $1,627.97
Maxcyte (di) (MXCT) Director name: Johnston ,John Amount sold: 366 @ $4.62 Value: $1,394.34
Maxcyte (di) (MXCT) Director name: Johnston ,John Amount sold: 226 @ $4.61 Value: $860.06
Maxcyte (di) (MXCT) Director name: Johnston ,John Amount sold: 180 @ $4.61 Value: $683.52
Maxcyte (di) (MXCT) Director name: Johnston ,John Amount sold: 100 @ $4.51 Value: $371.90
Maxcyte (di) (MXCT) Director name: Johnston ,John Amount sold: 63 @ $4.59 Value: $238.58
Maxcyte (di) (MXCT) Director name: Johnston ,John Amount sold: 12 @ $4.58 Value: $45.32
Share this article
Related Sharecast Articles
Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.
Award-winning online share dealing
Search, compare and select from thousands of shares.
Expert insights into investing your money
Our team of experts explore the world of share dealing.
Policies and important information
Accessibility | Conflicts of interest statement | Consumer Duty Target Market | Consumer Duty Value Assessment Statement | Cookie policy | Diversity, Equity & Inclusion | Doing Business with Fidelity | Diversity, Equity & Inclusion Reports | Investing in Fidelity funds | Legal information | Modern slavery | Mutual respect policy | Privacy statement | Remuneration policy | Staying secure | Statutory and Regulatory disclosures | Whistleblowing programme
Please remember that past performance is not necessarily a guide to future performance, the performance of investments is not guaranteed, and the value of your investments can go down as well as up, so you may get back less than you invest. When investments have particular tax features, these will depend on your personal circumstances and tax rules may change in the future. This website does not contain any personal recommendations for a particular course of action, service or product. You should regularly review your investment objectives and choices and, if you are unsure whether an investment is suitable for you, you should contact an authorised financial adviser. Before opening an account, please read the ‘Doing Business with Fidelity’ document which incorporates our client terms. Prior to investing into a fund, please read the relevant key information document which contains important information about the fund.
This website is issued by Financial Administration Services Limited, which is authorised and regulated by the Financial Conduct Authority (FCA) (FCA Register number 122169) and registered in England and Wales under company number 1629709 whose registered address is Beech Gate, Millfield Lane, Lower Kingswood, Tadworth, Surrey, KT20 6RP.
